Sooma welcomes a new Scientific Board Member We are thrilled to announce the addition of a new member to our Scientific Advisory Board (SAB). This brings the… Read more
Sooma joins the Finnish Startup Community A new community for startups has been born today in Finland. The Finnish Startup Community (Suomen startup-yhteisö) is a community… Read more
New U.S. patent granted to Sooma’s electrode structure Sooma Medical has been granted a new U.S. patent for its stimulation electrode. The electrode technology is an essential… Read more
New European regulation identifies brain stimulation devices approved for medical use Understanding medical device regulations can be a struggle. Rapid technological development is often a headache in terms of regulations, and… Read more
Status Update: Coronavirus situation and Home-based tDCS as a treatment alternative With the ongoing situation concerning the corona virus, we would like to give you an update on how this affects… Read more
Sooma Medical enters into procurement agreement with VSSHP The Hospital District of Southwest Finland (VSSHP) has entered into a procurement agreement with Sooma Oy for the procurement of… Read more
Sooma Closes an Investment Round of Over 1.2 Million EUR Sooma Closes an Investment Round of Over 1.2 Million EUR Sooma Oy, a Finnish medical device company developing non-invasive brain… Read more
Sooma Medical Awarded US Patent for Advanced Stimulation Electrode Official Press Release Helsinki, Finland, January 11, 2019 (Newswire.com) – Sooma Medical announces receipt… Read more
Sooma accepted into the Young Innovative Companies program of Business Finland We are happy to announce that Sooma Oy has been accepted into the Young Innovative Companies (YIC) program of Business… Read more
Sooma depression treatment receives HSA approval in Singapore Helsinki, Finland – December 12, 2017 Sooma Oy is proud to announce that it has received Singapore’s Health Sciences Authority (HSA)… Read more
